Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Bladder Cancer Clinical Trials

106 recruiting trials for Bladder Cancer. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
106
Total Trials
106
Recruiting Now
10
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT06528990

Telehealth Intervention for Ostomy Self-Management

Over one million individuals in the U.S. have ostomies. An ostomy is a surgical procedure that creates an opening in the abdominal wall that allows bodily waste (urinary or fecal)...

Sponsor: City of Hope Medical CenterEnrolling: 1501 location
RECRUITINGPhase 1NCT07217171

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced...

The goal of this study is to evaluate the safety and effectiveness of EVOLVE104 in participants with advanced urothelial and squamous cell carcinomas who have previously taken...

Sponsor: EvolveImmune United, IncEnrolling: 1609 locations
RECRUITINGNCT07327489

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a...

Sponsor: ElephasEnrolling: 20008 locations
RECRUITINGNCT07403630

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN...

This is a multicenter, experimental preclinical study conducted on primary samples from patients diagnosed with hematological or solid neoplasms defined as high risk. The study...

Sponsor: Azienda Ospedaliero-Universitaria di ParmaEnrolling: 3002 locations
RECRUITINGNCT06440018

INSPIRE: a Multi-Cancer Early Detection Study

This research constitutes a multi-centric, case-control designed investigation aimed at developing and implementing a blinded validation of a machine learning-powered,...

Sponsor: Singlera Genomics Inc.Enrolling: 53501 location
RECRUITINGPhase 1 / Phase 2NCT06814496

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24 patients with...

Sponsor: University of ArizonaEnrolling: 301 location
RECRUITINGPhase 1 / Phase 2NCT05086692

A Beta-only IL-2 ImmunoTherapY Study

This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor...

Sponsor: Medicenna Therapeutics, Inc.Enrolling: 11520 locations
RECRUITINGNCT06040762

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and...

Prehabilitation refers to the process of improving a patient's functional capabilities prior to a surgical procedure with the goal of decreasing post-surgical inactivity and...

Sponsor: University of WashingtonEnrolling: 1281 location
RECRUITINGNCT04923178

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Background: Tumors in the genitourinary tracts can occur in the kidney, bladder, prostate, and testicles and can have common and rare histologies. Some cancers that occur along...

Sponsor: National Cancer Institute (NCI)Enrolling: 11001 location
RECRUITINGNCT06337942

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

The goal of this clinical trial is to demonstrate the feasibility of bladder transplantation in patients with terminal bladder diseases who would benefit from a new bladder or a...

Sponsor: University of California, Los AngelesEnrolling: 51 location
RECRUITINGNCT05056077

Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)

This clinical trial studies the effect of four different intervention components "tools" on body weight, nutrition, and physical activity in cancer survivors. Studies indicate...

Sponsor: University of California, San FranciscoEnrolling: 10001 location
RECRUITINGNCT00026884

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

Selected individuals suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may be collected at the...

Sponsor: National Cancer Institute (NCI)Enrolling: 59501 location
RECRUITINGPhase 2NCT06663137

Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC

This is a prospective, single-arm study evaluating the safety and efficacy of NDV01 KIT, a fixed-dose combination of gemcitabine HCl and docetaxel, administered via intravesical...

Sponsor: Relmada Therapeutics, Inc.Enrolling: 701 location
RECRUITINGPhase 3NCT05024773

Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

This is a phase III, single-arm, multicenter, international study to assess the efficacy and safety of ONCOFID-P-B following intravesical instillation in adult patients with...

Sponsor: Fidia Farmaceutici s.p.a.Enrolling: 11220 locations
RECRUITINGNCT06909643

Development and Prospective Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the Efficacy...

This study is a multi-center observational study without interventions, including the construction of an AI diagnostic model and retrospective testing of a multi-center cohort....

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityEnrolling: 5501 location
RECRUITINGPhase 2NCT06892860

Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer

This is an adaptive, open-label, randomised phase II trial that aims to evaluate the impact of 3 vs 6 cycles of first-line platinum-based chemotherapy followed by maintenance...

Sponsor: Queen Mary University of LondonEnrolling: 3203 locations
RECRUITINGNCT03193541

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of...

Sponsor: Cedars-Sinai Medical CenterEnrolling: 9008 locations
RECRUITINGNCT04979156

LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors

Conventional monopolar or bipolar transurethral resection of bladder tumors is the most common method for resection of a bladder mass. En bloc resection has demonstrated success...

Sponsor: University of Kansas Medical CenterEnrolling: 201 location
RECRUITINGPhase 2NCT06983210

Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma

【Treatment of Urothelial Carcinoma】 Treatment for urothelial carcinoma includes surgery, chemotherapy (anticancer drugs), and radiation therapy. Chemotherapy is generally used...

Sponsor: Nagoya UniversityEnrolling: 431 location
RECRUITINGNCT05558111

The Supraspinal Control of Lower Urinary Tract Function in Patients with Orthotopic Sigmoid Neobladder.

Orthotopic sigmoid neobladder surgery is one of the ideal urinary diversion methods after radical cystectomy.In recent years, functional imaging studies have revealed brain...

Sponsor: Zhujiang HospitalEnrolling: 401 location
RECRUITINGPhase 2NCT05957757

RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression

This is a prospective, open, single-center clinical study of anti-HER2-ADC combined with PD-1 monoclonal antibody for bladder sparing treatment in non-muscular invasive bladder...

Sponsor: RenJi HospitalEnrolling: 201 location
RECRUITINGPhase 2NCT03375307

Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other...

This phase II trial studies how well olaparib works in treating patients with bladder cancer and other genitourinary tumors with deoxyribonucleic acid (DNA)-repair defects that...

Sponsor: National Cancer Institute (NCI)Enrolling: 6017 locations
RECRUITINGPhase 1 / Phase 2NCT05410730

A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC

The study is to evaluate the safety and tolerability of SHR-1501 alone or in combination with BCG or SHR-1316 in the patients with NMIBC, and to determine the RP2D of SHR-1501 in...

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.Enrolling: 1501 location
RECRUITINGPhase 3NCT06651697

BladdEr Full OR Empty for Pelvic Radiation Therapy

The present study evaluates empty and full bladder protocols for radiation therapy of genitourinary (GU), gynecological (Gyn), and gastrointestinal (GI) malignancies of the pelvis.

Sponsor: University of California, San DiegoEnrolling: 3001 location
RECRUITINGPhase 1 / Phase 2NCT06704191

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

This phase Ib/II trial compares the safety, tolerability and acceptability of intravesical chemotherapy given at home to in-clinic administration in patients with non-muscle...

Sponsor: Mayo ClinicEnrolling: 401 location
RECRUITINGPhase 2NCT06263153

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer...

This phase II trial tests how well the combination of futibatinib and durvalumab given before cystectomy works in treating patients with muscle-invasive bladder cancer (MIBC) who...

Sponsor: Yuanquan YangEnrolling: 243 locations
RECRUITINGPhase 2 / Phase 3NCT06225596

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

This is a global, multicenter, randomized, open-label study, with an adaptive design. The main objective of the study is to measure the efficacy and safety of BT8009 (zelenectide...

Sponsor: BicycleTx LimitedEnrolling: 95620 locations
RECRUITINGNCT06595446

A Feasibility Randomized Trial Evaluating Early vs Late Stent Removal Following Radical Cystectomy and Ileal Conduit...

Bladder cancer is the 4th most common cancer in men and 5th most common type of cancer in Canada. Urothelial cancer accounts for approximately 90% of malignancies. At diagnosis,...

Sponsor: Western University, CanadaEnrolling: 601 location
RECRUITINGPhase 1 / Phase 2NCT07222488

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

Researchers are looking for new ways to treat high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder and has...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 4511 locations
RECRUITINGNCT06421142

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

The aim of this trial is to investigate the value of FAPI PET/MRI, FDG PET/MRI and MRI in diagnosing MIBC and predicting the efficacy of neoadjuvant therapy for MIBC patients, so...

Sponsor: First Affiliated Hospital of Fujian Medical UniversityEnrolling: 801 location
RECRUITINGNCT07309445

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer...

The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs...

Sponsor: Janssen Research & Development, LLCEnrolling: 1501 location
RECRUITINGNCT07202819

Effect of Neoadjuvant Chemotherapy on MRI Accuracy Before Cystectomy

The goal of this clinical trial is to learn if neoadjuvant chemotherapy (NAC) affects the accuracy of magnetic resonance imaging (MRI) in staging muscle-invasive bladder cancer...

Sponsor: Assiut UniversityEnrolling: 762 locations
RECRUITINGNCT06269536

Stress-reducing Intervention in Urothelial Carcinoma

The aim of this interventional study is to test the heart-rate variability biofeedback intervention (HRV BI) in patients with muscle-infiltrating bladder carcinoma (MIBC) treated...

Sponsor: Comenius UniversityEnrolling: 501 location
RECRUITINGNCT06373419

TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors

The goal of this randomized clinical trial is to determine if there is difference in pathological and clinical outcomes between MOSES and TFL in the transurethral laser...

Sponsor: Thunder Bay Regional Health Research InstituteEnrolling: 1001 location
RECRUITINGPhase 1NCT06108492

A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk...

This study is an open-label, multicenter Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-2005 for Intravesical perfusion in...

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.Enrolling: 1701 location
RECRUITINGNCT06972771

Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer

Bladder cancer ranks as the fourth most common malignancy among males the United States . Approximately 75% of patients present with non-muscle-invasive bladder cancer (NMIBC)....

Sponsor: Yunnan Cancer HospitalEnrolling: 301 location
RECRUITINGNCT06988696

The Effect of Perioperative Heated Sock Application on Hypothermia and Vital Signs in Bladder Tumor Surgery

The aim of this study is to evaluate the effect of perioperative use of heated socks on the prevention of hypothermia and its impact on vital signs in patients undergoing bladder...

Sponsor: Istanbul University - CerrahpasaEnrolling: 901 location
RECRUITINGPhase 4NCT06709196

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to...

The aim of this trial is to test whether postoperative antibiotics targeted towards bacteria in the urine can reduce the risk of infection after surgical removal of the bladder...

Sponsor: Rigshospitalet, DenmarkEnrolling: 2485 locations
RECRUITINGNCT07204132

Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy

Professional Translation: This study is a single-center, prospective, non-randomized, parallel-controlled clinical trial initiated and conducted by the Department of Urology at...

Sponsor: Changhai HospitalEnrolling: 1801 location
RECRUITINGNCT05790850

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

The PRIMER (Pre-Habilitation With Mindfulness and Exercise for Patients Undergoing Radical Cystectomy) trial is a pilot designed to estimate the feasibility of integrating a...

Sponsor: University of VirginiaEnrolling: 301 location
RECRUITINGPhase 2NCT05969860

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to...

Sponsor: Mayo ClinicEnrolling: 2202 locations
RECRUITINGPhase 2NCT07087860

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

This phase II trial compares therapeutic plasma exchange followed by enfortumab vedotin and pembrolizumab to standard of care next-line therapy for the treatment of patients with...

Sponsor: Mayo ClinicEnrolling: 701 location
RECRUITINGNCT06729346

Is the Normal Looking Bladder Mucosa on WL Cystoscopy During TURBT Really Normal and Can NBI Detect Hidden Tumor

As every urologist does transurethral resection of bladder tumor. So there are instances in which the operating surgeon is not sure whether the normal-looking mucosa or the...

Sponsor: Armed Forces Institute of Urology, RawalpindiEnrolling: 1002 locations
RECRUITINGNCT05779631

Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm

A two-arm multicenter randomised controlled trial, comparing progression free survival, time to definitive treatment and cost-effectiveness of the standard of care (TURBT) and...

Sponsor: Radboud University Medical CenterEnrolling: 36019 locations
RECRUITINGPhase 1NCT07492628

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

This hypothetical first-in-human study is designed to evaluate the safety, feasibility, and preliminary anti-tumor activity of an allogeneic dual-target Nectin-4/HER2 CAR-NK cell...

Sponsor: Beijing BiotechEnrolling: 421 location
RECRUITINGNCT06818136

Bladder EpiCheck European Haematuria Study

The goal of this observational study is to further validate the sensitivity and specificity of Bladder EpiCheck in primary detection of urothelial carcinoma in participants aged...

Sponsor: Nucleix Ltd.Enrolling: 8005 locations
RECRUITINGNCT06891209

Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy

This study explores and compares health-related quality of life and urinary outcomes in postoperative partial cystectomy and matched radical cystectomy patients.

Sponsor: Mayo ClinicEnrolling: 10001 location
RECRUITINGPhase 2NCT03379909

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer

A multi-center, open-label, phase II clinical study of metformin in up to evaluable 49 patients with low-grade NMIBC with the aim to determine the overall response to...

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 493 locations
RECRUITINGNCT07048496

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance...

Sponsor: University of PennsylvaniaEnrolling: 501 location
RECRUITINGPhase 2NCT06833073

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Researchers are looking for new ways to treat people with high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 30820 locations

Showing 50 of 106 trials.Search all Bladder Cancer trials